Campbell Rogers - 13 Oct 2021 Form 4 Insider Report for InspireMD, Inc. (NSPR)

Reporting relationship: Director
Issuer ticker: NSPR
Reported as of: 13 Oct 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Oct 2021, 17:00:45 UTC
Next SEC filing: 07 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Craig Shore, Attorney-in-Fact for Campbell Rogers

Key filing fact

Campbell Rogers filed Form 4 for InspireMD, Inc. (NSPR) on 14 Oct 2021.

Key facts

This page summarizes Campbell Rogers's Form 4 filing for InspireMD, Inc. (NSPR).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Oct 2021, 17:00.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NSPR transaction

Common Stock

Award

Transaction value: $0
Shares: +17,248
Change %: +161%
Price: $0.000000
Shares after: 27,960
Date: 13 Oct 2021
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NSPR transaction Derivative

Options to purchase common stock (right to buy)

Award

Transaction value: $0
Shares: +5,749
Change %
Price: $0.000000
Shares after: 5,749
Date: 13 Oct 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,749
Exercise price: $4.12
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.

Footnote F2

The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.